申请人:Endo Pharmaceuticals Inc.
公开号:US20140221315A1
公开(公告)日:2014-08-07
The present application provides novel pyrimido-pyridazinone compounds and methods for preparing and using these compounds. These compounds are useful in treating inflammation in patients by administering one or more of the compounds to a patient. In one embodiment, the novel pyrimido-pyridazinone compound is of Formula (I) and R
1
and R
2
are defined herein.
本申请提供了新型嘧啶并吡啶嗪酮化合物以及制备和使用这些化合物的方法。通过向患者投药一种或多种化合物,这些化合物可用于治疗患者的炎症。在一种实施方式中,新型嘧啶并吡啶嗪酮化合物为公式(I)中的化合物,其中R1和R2在此定义。